STI Screening in Early Pregnancy: Complete Protocol

A positive home pregnancy test is just the beginning of the testing protocol. STIs during pregnancy carry real risks, including preterm birth, stillbirth, and transmission to the newborn during delivery. The infections most likely to cause harm are also the ones least likely to produce any symptoms. That’s why routine screening, not symptom-based testing, is the standard of care from the first prenatal visit forward.

The earliest signs of pregnancy send most people to their provider for confirmation. That first appointment is also when the baseline STI panel is drawn. Most patients leave with a prenatal vitamin prescription and very little information about what was just ordered, or why. This guide explains the full protocol: what each test detects, when repeat screening applies, and what a positive result actually means for the pregnancy.

This content is developed by medical and public health professionals with expertise in infectious diseases and women’s health, in keeping with the research standards described at LesbianSTD.com’s site policies. It draws from current CDC and ACOG guidelines and peer-reviewed clinical evidence.

What Is Prenatal STI Screening?

Prenatal STI screening is a structured series of blood, urine, and swab tests ordered at defined points in pregnancy to detect infections that could affect the pregnant person, the fetus, or the newborn. The first panel runs at the initial prenatal visit, usually between 8 and 12 weeks gestation. High-risk patients receive repeat testing in the third trimester.

The clinical logic is simple. Untreated syphilis in pregnancy leads to stillbirth in up to 40% of cases. Untreated chlamydia can cause preterm delivery and neonatal eye infections or pneumonia. HIV, identified early, responds to antiretroviral therapy that reduces mother-to-child transmission to under 1%. Early detection changes outcomes. That’s the rationale for universal, not targeted, screening across the board.

When Do They Test for STDs During Pregnancy?

Most STI testing is ordered at the first prenatal visit. For patients at elevated risk, repeat screening happens in the third trimester, roughly 28 to 36 weeks. Group B Strep is tested specifically at 35 to 37 weeks because timing directly affects delivery management.

• First prenatal visit (8–12 weeks): HIV, syphilis, hepatitis B, hepatitis C, chlamydia, gonorrhea, rubella immunity
• First trimester with risk factors: Repeat gonorrhea and syphilis for high-risk patients
• Third trimester (28–36 weeks): Repeat HIV, syphilis, gonorrhea, and chlamydia for high-risk individuals
• 35–37 weeks: Group B Streptococcus (GBS) vaginal and rectal swab

Jenna Hardy, whose evidence-based sexual health work informs the resources at LesbianSTD.com, notes that hepatitis C screening shifted from risk-based to universal in pregnancy starting in 2020, per updated CDC guidance. Many patients still don’t know to ask whether it’s included in their panel.

CDC STI Screening Guidelines During Pregnancy

The CDC recommends universal STI screening at the first prenatal visit for HIV, syphilis, hepatitis B, hepatitis C, chlamydia, and gonorrhea. Patients with multiple partners, inconsistent barrier use, or a prior history of STIs are considered high-risk and should be rescreened in the third trimester.

“Pregnant women should be screened for syphilis, HIV, and hepatitis B at their first prenatal visit. Pregnant women at high risk for these infections should be rescreened during the third trimester.”

— CDC STI Treatment Guidelines, Screening Recommendations

The CDC also recommends rescreening for gonorrhea and chlamydia in the third trimester for patients under 25 or those with new or multiple partners. Trichomonas vaginalis screening is recommended for HIV-positive pregnant women. For HIV-negative patients, trichomonas testing is offered based on clinical judgment. Bacterial vaginosis is not universally screened unless symptoms are present, though providers may screen high-risk patients at their discretion.

ACOG STI Screening Guidelines: What Your OB Follows

ACOG guidelines largely mirror CDC recommendations but add clinical nuance for obstetric providers. ACOG supports universal chlamydia and gonorrhea screening for all sexually active pregnant women under 25, and for older women with identified risk factors. Both organizations align on universal HIV opt-out testing at the first prenatal visit, meaning testing is performed unless the patient specifically declines.

On herpes simplex virus, ACOG takes a specific position. Routine serologic HSV screening is not recommended for asymptomatic pregnant women. But patients with a personal history of genital herpes may be offered suppressive antiviral therapy starting at 36 weeks to reduce neonatal transmission risk during vaginal delivery. That’s a clinical nuance worth discussing with your provider if herpes is part of your history.

“A first prenatal visit typically includes blood tests for blood type and Rh factor, a complete blood count, and infections such as syphilis, HIV, and hepatitis B, as well as immunity checks for certain diseases.”

— Mayo Clinic, Prenatal Care: First Trimester Visits

ACOG also specifies that chlamydia-positive patients in pregnancy should be treated with azithromycin or amoxicillin and retested 3 to 4 weeks after completing treatment to confirm clearance. This test of cure is not optional. It’s a required step before moving forward.

What Is Included in a Full STD Panel During Pregnancy?

A standard prenatal STI panel covers eight to ten conditions. The exact tests depend on risk profile and provider workflow, but these components are consistent across guidelines.

• HIV: 4th-generation antigen/antibody combination test
• Syphilis: RPR or VDRL, confirmed with a treponemal test if reactive
• Hepatitis B: Hepatitis B surface antigen (HBsAg)
• Hepatitis C: Anti-HCV antibody test
• Chlamydia: NAAT from urine or cervical swab
• Gonorrhea: NAAT, often run from the same specimen as chlamydia
• Rubella immunity: IgG antibody titer
• Group B Strep: Vaginal and rectal swab at 35–37 weeks

Providers may add trichomonas NAAT, varicella immunity testing, or bacterial vaginosis assessment depending on history. The sexual health resources at LesbianSTD.com cover each of these conditions individually, including diagnostic criteria and what treatment involves.

Symptoms of STD While Pregnant: What Actually Warrants a Call

Most STIs in pregnancy produce no noticeable symptoms. That’s the core reason routine screening exists. Don’t wait for signs. But some infections do produce signals that warrant evaluation outside scheduled visits.

Contact your provider promptly if you notice:

• Unusual vaginal discharge, especially gray, green, or frothy
• Burning or pain with urination
• Genital sores, ulcers, or blisters
• Pelvic pain or pressure that’s new or worsening
• A rash on the palms, soles, or trunk
• Fever alongside any genital symptom

Some normal pregnancy changes, including increased vaginal discharge and mild pelvic pressure, can mimic infection symptoms. Don’t self-diagnose. Call your provider. And note that severe one-sided pelvic pain paired with a positive pregnancy test should be evaluated urgently as a possible ectopic pregnancy, not assumed to be an STI. Symptoms of ectopic pregnancy overlap significantly with pelvic infection signs, and early evaluation is critical.

Who Should Expect Expanded or Repeat Screening?

Routine screening covers the majority of cases. Some patients warrant more. If you have a history of STIs, multiple sexual partners, inconsistent barrier use, or a partner with a known infection, expanded or repeated testing is appropriate and clinically supported, not a judgment call about behavior.

HIV-positive pregnant women should be screened for trichomonas at the first prenatal visit and again in the third trimester. HIV-negative women with risk factors may also receive trichomonas screening based on provider judgment.

Women who have sex with women aren’t exempt from STI risk during pregnancy. Partner gender doesn’t eliminate transmission risk, particularly for bacterial infections and viral STIs transmitted through skin-to-skin or fluid contact. If you had a new partner after your first prenatal visit, disclose that to your provider. Repeat screening is clinically appropriate and supported by the evidence-based care framework at LesbianSTD.com’s sexual health resources, which address woman-to-woman transmission contexts that most prenatal references leave out entirely.

What to Expect After a Positive Prenatal STI Result

A positive result is manageable in most cases. Bacterial STIs, including chlamydia, gonorrhea, and syphilis, respond to antibiotics that are safe during pregnancy. Viral infections including HIV and hepatitis B and C have established management protocols that significantly reduce fetal and neonatal risk when treatment starts early.

The typical sequence after a positive finding:

1. Confirmation: Some initial screens require confirmatory testing before treatment begins.
2. Treatment: Antibiotics or antivirals appropriate to the specific infection and trimester.
3. Test of cure: Required for chlamydia and gonorrhea at 3 to 4 weeks post-treatment.
4. Partner notification: Current sexual partners should be tested and treated to prevent reinfection before or during pregnancy.
5. Repeat screening: High-risk patients are rescreened in the third trimester regardless of earlier results.

Anxiety after a positive result is understandable. Treatment works. Research compiled by the NIH consistently shows that early identification and treatment prevents the vast majority of pregnancy complications linked to STIs. Most bacterial STIs clear within one to two weeks of completing the prescribed antibiotic course.

Practical Tips for Your Prenatal Screening Visit

1. Bring a list of current medications and supplements. Some interact with treatment options or testing protocols.
2. Be honest about your sexual history. Providers use this to calibrate risk and customize the panel. Nothing you share should trigger judgment in a clinical setting.
3. Ask specifically about hepatitis C. Some clinics haven’t updated to universal HCV screening in pregnancy. Confirm it’s included in your panel.
4. Request a copy of your results. You have the right to see your lab work. Baseline values matter for tracking any changes that develop later in the pregnancy.
5. Don’t wait for symptoms. The point of prenatal STI screening is that most infections don’t produce them.
6. Ask about your partner’s testing status. If you haven’t both been recently screened, this is the right moment to address that gap.

Prenatal STI screening is one of the most effective interventions in pregnancy care, not because the infections are common, but because the consequences of missing them are preventable. You don’t need symptoms to request testing. You don’t need to wait to be asked. At your first prenatal visit, confirm the full recommended panel is included. Know what was ordered and why. Ask about repeat screening if your risk profile has changed. Your pregnancy and your newborn’s health benefit directly from that clarity, and the earlier you have it, the more options you have.